HomeIMMX • NASDAQ
add
Immix Biopharma Inc
Previous close
$2.18
Day range
$2.05 - $2.15
Year range
$1.55 - $7.75
Market cap
56.24M USD
Avg Volume
129.59K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 5.59M | 121.76% |
Net income | -5.26M | -112.08% |
Net profit margin | — | — |
Earnings per share | -0.22 | -22.22% |
EBITDA | -5.59M | -121.69% |
Effective tax rate | -0.17% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 29.32M | 155.77% |
Total assets | 34.35M | 159.98% |
Total liabilities | 6.72M | 355.94% |
Total equity | 27.63M | — |
Shares outstanding | 26.41M | — |
Price to book | 2.06 | — |
Return on assets | -51.50% | — |
Return on capital | -62.21% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -5.26M | -112.08% |
Cash from operations | -3.83M | -82.93% |
Cash from investing | -301.91K | — |
Cash from financing | 15.95M | 13,311.62% |
Net change in cash | 11.81M | 698.36% |
Free cash flow | -3.19M | -176.24% |
About
Founded
2012
Headquarters
Website
Employees
14